Clinical Trial Update: A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study of luspatercept in lower-risk myelodysplastic syndrome; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Myelodysplastic Syndromes | Phase 3 | Status: ACTIVE_NOT_RECRUITING